MiR-138–5p inhibits prostate cancer cell proliferation and chemoresistance by targeting APOBEC3B

Docetaxel is one of the most commonly used drugs in prostate cancer (PCa) chemotherapy, but its therapeutic effect in PCa is usually limited due to its drug resistance. APOBEC3B is a DNA cytosine deaminase that can alter biological processes, including chemoresistance. APOBEC3B is upregulated in var...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Lina, Zhang, Yan, Hu, Xi, Zhang, Hui, Jiang, Chenyang, Guo, Yan, Cang, Shundong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302536/
https://www.ncbi.nlm.nih.gov/pubmed/37364333
http://dx.doi.org/10.1016/j.tranon.2023.101723

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302536/
https://www.ncbi.nlm.nih.gov/pubmed/37364333
http://dx.doi.org/10.1016/j.tranon.2023.101723

Ejemplares similares